O TYM ODCINKU
Scientific breakthroughs get the attention. But between a promising discovery and a product that reaches patients lies another challenge entirely: can you actually make it - reliably, affordably, and at scale?
In this episode of The Commons, host Thomas Osha sits down with Behrad Vahidi of SCHOTT MINIFAB to explore the often-overlooked world of microfluidics, diagnostic consumables, and design for manufacturing.
Vahidi explains how lab-on-a-chip technologies can move complex testing out of centralized laboratories and closer to patients while reducing reagent use, lowering costs, and increasing reproducibility. But achieving that promise requires thinking about manufacturing much earlier than many innovators realize.
Their conversation explores why a prototype that works ten times may fail when produced a million times, how startups can avoid costly redesigns by incorporating manufacturability from the beginning, and the role sophisticated pilot manufacturing infrastructure can play in helping young companies reach clinical validation without enormous upfront capital investment.
The discussion also turns to university commercialization and an important question: Should manufacturing expertise have a seat at the table much earlier when researchers begin translating discoveries into companies?
It's a fascinating look at the largely invisible engineering and infrastructure that turns promising science into products capable of changing lives.
